Cargando…
Cell-based laboratory evaluation of coagulation activation by antineoplastic drugs for the treatment of lymphoid tumors
OBJECTIVES: Combining vorinostat, L-asparaginase, and doxorubicin (Dox) led to improved response rates in the treatment of lymphoid tumors. However, deep-vein thrombosis has been noted as one of the most serious side effects with these drugs, and how these regimens cause deep-vein thrombosis is uncl...
Autores principales: | Tsunaka, Misae, Arai, Reina, Ohashi, Ayaka, Koyama, Takatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963813/ https://www.ncbi.nlm.nih.gov/pubmed/27504186 http://dx.doi.org/10.1177/2050312116660936 |
Ejemplares similares
-
Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia
por: Tsunaka, Misae, et al.
Publicado: (2017) -
Activation of Coagulation by Lenalidomide-Based Regimens for the Treatment of Multiple Myeloma
por: Isozumi, Yu, et al.
Publicado: (2013) -
Laboratory variables as predictors of progression in gastroenteropancreatic neuroendocrine tumors in different lines of antineoplastic treatments
por: Armentano, Daniela Pezzutti Domigues, et al.
Publicado: (2022) -
Tumor targeting using liposomal antineoplastic drugs
por: Huwyler, Jörg, et al.
Publicado: (2008) -
Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990)